Editas Medicine Inc. logo

EDIT

Editas Medicine Inc.

$8.86

Earnings Summary

Revenue
$5.34Mn
Net Profits
$-45.02Mn
Net Profit Margins
-843.68%

Highlights

Revenue:

Editas Medicine Inc.’s revenue jumped 12604.76% since last year same period to $5.34Mn in the Q3 2023. On a quarterly growth basis, Editas Medicine Inc. has generated 84.83% jump in its revenue since last 3-months.

Net Profits:

Editas Medicine Inc.’s net profit jumped 16.53% since last year same period to $-45.02Mn in the Q3 2023. On a quarterly growth basis, Editas Medicine Inc. has generated -11.74% fall in its net profits since last 3-months.

Net Profit Margins:

Editas Medicine Inc.’s net profit margin jumped 99.34% since last year same period to -843.68% in the Q3 2023. On a quarterly growth basis, Editas Medicine Inc. has generated 39.55% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Editas Medicine Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.6
EPS Estimate Current Year
-0.6

Highlights

EPS Estimate Current Quarter:

Editas Medicine Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.6 - a -10.59% fall from last quarter’s estimates.

EPS Estimate Current Year:

Editas Medicine Inc.’s earning per share (EPS) estimates for the current year stand at -0.6.

Key Ratios

Key ratios of the Editas Medicine Inc. post its Q3 2023 earnings

Earning Per Share (EPS)
-0.55
Return on Assets (ROA)
-0.25
Return on Equity (ROE)
-0.5

Highlights

Earning Per Share (EPS):

Editas Medicine Inc.’s earning per share (EPS) jumped 32.1% since last year same period to -0.55 in the Q3 2023. This indicates that the Editas Medicine Inc. has generated 32.1% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Editas Medicine Inc.’s return on assets (ROA) stands at -0.25.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Editas Medicine Inc.’s return on equity (ROE) stands at -0.5.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-03
-0.57
-0.55
3.51%
2023-08-02
-0.76
-0.56
26.32%
2023-05-05
-0.78
-0.71
8.97%